Effects of Tumors and Viruses on Lactic Dehydrogenase in Mice
Author Information
Author(s): D. H. Adams, K. E. K. Rowson, M. H. Salaman
Primary Institution: Cancer Research Department, London Hospital Medical College
Hypothesis
Can plasma lactic dehydrogenase (PLDH) levels serve as an early assay for leukaemogenic and tumor-producing viruses?
Conclusion
The study found that PLDH levels rise significantly in mice with tumors and leukaemia, but measurements of PLDH activity are not reliable as an early indication of viral infection.
Supporting Evidence
- PLDH activity rose from 400 to about 4000 units in three days after inoculation with Sarcoma 37.
- AKR mice showed a continuous rise in PLDH up to 40,000 units by the 12th day after inoculation with leukaemic tissue.
- Plasma from S37-bearing mice transmitted the early effect on PLDH activity to other mice.
Takeaway
When mice have tumors or leukaemia, a substance in their blood makes a certain enzyme level go up, but this doesn't help us find out if they have a virus early on.
Methodology
Mice were inoculated with tumor tissues or viruses, and their plasma lactic dehydrogenase activity was measured at intervals.
Limitations
PLDH levels cannot serve as an early indication of infection by leukaemogenic viruses.
Participant Demographics
Mice of CBA and AKR inbred strains, as well as a heterogeneous stock albino strain.
Want to read the original?
Access the complete publication on the publisher's website